# Pipeline Activity Log

> **Review:** Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection  
> **Date:** 2026-06-11 19:49  
> **Duration:** 13m 17s  
> **Total tokens:** 150,666 (input: 90,471 / output: 60,195)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003508.pub2/full  
> **Dataset split:** HIV_test  
> **Studies:** 10  
> **Model Profile:** multimodel_openrouter  
> **Orchestrator Model:** openai | openai/gpt-5  
> **Orchestrator API Base:** https://openrouter.ai/api/v1  
> **Orchestrator Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Librarian Model:** openai | openai/gpt-5  
> **Librarian API Base:** https://openrouter.ai/api/v1  
> **Librarian Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Gatekeeper Model:** openai | deepseek/deepseek-v4-pro  
> **Gatekeeper API Base:** https://openrouter.ai/api/v1  
> **Gatekeeper Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["deepseek"], "require_parameters": true}, "reasoning": {"effort": "xhigh", "enabled": true}}}  
> **Miner Model:** openai | openai/gpt-5  
> **Miner API Base:** https://openrouter.ai/api/v1  
> **Miner Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Critic Model:** openai | openai/gpt-5  
> **Critic API Base:** https://openrouter.ai/api/v1  
> **Critic Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 7 | 11m 31s | 51,904 / 18,767 |
| Librarian | 4 | 3m 03s | 17,611 / 13,675 |
| Gatekeeper | 1 | 36s | 7,648 / 2,968 |
| Miner | 2 | 2m 57s | 8,585 / 17,273 |
| Critic | 1 | 1m 26s | 4,723 / 7,512 |
| **Total** | **15** | **13m 17s** | **90,471 / 60,195** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*19:50:43 — 58s — 6,762 tokens*

The orchestrator clarified the review objective and set inclusion criteria focused on randomized or quasi-randomized trials of routine cotrimoxazole versus placebo/no prophylaxis in HIV-infected children or HIV-exposed infants. It laid out a stepwise workflow to search databases and registries, screen records, and extract key details on study design, settings, populations, cotrimoxazole regimens, comparators, outcomes (mortality, illness episodes, adverse events, antimicrobial resistance), and follow-up. Tasks were assigned to specialized agents for searching, screening, extraction, quality checking, and report generation, with plans to save structured evidence and search documentation. Outcome: a clear, ready-to-execute plan for the next pipeline stages.

---

### 2. Orchestrator → Librarian

*19:54:08 — 3m 25s — 40,756 tokens*

The orchestrator initiated the search phase by defining the review question and eligibility criteria (randomised/quasi-randomised trials of routine cotrimoxazole prophylaxis vs placebo/no prophylaxis in HIV-infected children or HIV-exposed infants) and instructing the librarian to run a comprehensive, unrestricted search using relevant terms. It requested de-duplicated trial records with key bibliographic details for later screening. After retrieving the results, it tallied 10 candidate studies for potential inclusion.

> **Librarian — Step 1:** The librarian intended to design and run a comprehensive search for randomized or quasi-randomized trials of routine cotrimoxazole prophylaxis in HIV-infected or HIV-exposed children. It first retrieved and reviewed the review protocol to confirm the question, target populations (children under 15 and infants of HIV-infected mothers), intervention (routine cotrimoxazole), comparators (placebo/no treatment), and eligible study designs. In this step, only the protocol was obtained; no database search or study retrieval was performed yet.
> **Librarian — Step 2:** The librarian confirmed the review protocol and documented a PICO-driven search plan for randomized and quasi-randomized trials of routine cotrimoxazole (trimethoprim-sulfamethoxazole) prophylaxis in children with HIV or HIV-exposed infants. The narrative specifies intervention synonyms, prophylaxis/prevention terms, HIV and pediatric population terms, outcome context (opportunistic infections, mortality), and trial design filters, with no date or language limits. This search strategy was saved to the review’s search record; no studies were retrieved in this step.
> **Librarian — Step 3:** The librarian agent set out to find randomized and quasi-randomized trials of cotrimoxazole (TMP-SMX) prophylaxis in HIV-infected or HIV-exposed children. It built a comprehensive Boolean search covering drug synonyms, prevention terms, HIV terminology, pediatric populations, and trial design filters, and ran this in the literature database. The search returned 10 candidate studies, including a pediatric double-blind RCT from Zambia (CHAP), and the raw results were captured for subsequent screening against the inclusion criteria (cotrimoxazole vs placebo/no treatment in children).
> **Librarian — Step 4 (result):** The librarian aimed to finalize the literature search on cotrimoxazole (TMP–SMX) prophylaxis for HIV, with emphasis on children and HIV-exposed infants. It converted raw search hits into structured study records (titles and abstracts), removed duplicates by title, and compiled a narrative summary of the search objectives, eligibility focus, and terms used. Outcome: 10 unique candidate studies were delivered for screening with their titles and abstracts.

---

### 3. Orchestrator → Gatekeeper

*19:55:13 — 1m 04s — 20,770 tokens*

The orchestrator ran the screening phase by directing a screening agent to assess all candidate studies against the protocol’s inclusion criteria (eligible populations, routine cotrimoxazole prophylaxis, appropriate comparators, and randomized designs). It then gathered the studies marked for inclusion and tallied them. Outcome: 1 study met the criteria and was retained for further review.

> **Gatekeeper — Step 1 (result):** The agent screened 10 candidate studies against the review criteria for randomized trials of cotrimoxazole prophylaxis in HIV-infected children. It included only the CHAP trial, which met all population, intervention, and design requirements, and excluded the other nine due to adult populations, non-randomized or observational designs, or lack of a relevant comparator. The final output records each study’s decision, rationale, and confidence.

---

### 4. Orchestrator → Miner

*19:58:47 — 3m 33s — 37,572 tokens*

The orchestrator initiated the evidence extraction phase, directing a specialist agent to pull structured PICO data from the included studies for the review. It requested details on study design and setting; population (age, HIV status, ART use); intervention and comparator regimens; key outcomes (all-cause mortality, illness episodes such as PCP and serious bacterial infections, hospitalizations), adverse events and resistance, follow-up; quantitative results (event counts, denominators/person-time, effect estimates or computed ratios); and risk-of-bias cues. The task ran to completion and reported success, but the extracted data are not shown in this log.

> **Miner — Step 1:** The agent set out to batch-extract structured PICO elements, outcomes, and effect measures from all included studies. It applied an automated evidence-extraction step to the single eligible RCT of cotrimoxazole prophylaxis in HIV-infected Zambian children, capturing key results from the abstract, including a mortality hazard ratio of 0.57 (95% CI 0.43–0.77), deaths of 74 vs 112, median follow-up of 19 months, and grade 3–4 adverse events of 6% vs 7%. The extraction completed successfully, producing structured findings for use in the evidence summary and narrative synthesis.
> **Miner — Step 2 (result):** The agent manually parsed the abstract of the CHAP randomized, double-blind trial in Zambia to extract PICO details, follow-up, and quantitative results. It recorded that daily cotrimoxazole vs placebo in HIV-infected children reduced all-cause mortality (HR 0.57, 95% CI 0.43–0.77; subgroup beyond 12 months HR 0.48) and summarized safety findings (grade 3/4 adverse events RR 0.86; severe neutropenia RR 2.0, p=0.06), noting outcomes without calculable effects (rash, PCP detection). The result is a structured evidence record with study design and key risk-of-bias cues documented.

---

### 5. Planning (Orchestrator)

*19:59:08 — 21s — 6,156 tokens*

The orchestrator reviewed the protocol for cotrimoxazole prophylaxis in children with or exposed to HIV, confirming the objective and eligibility criteria. It then outlined a stepwise plan: have the librarian retrieve studies, standardize the candidate set, screen against inclusion criteria, extract data from eligible trials, synthesize findings, and prepare a concise report. The outcome was a clear handoff and execution plan for the specialized agents, including instructions to save both the final report and structured evidence outputs.

---

### 6. Orchestrator → Critic

*20:00:58 — 1m 50s — 25,579 tokens*

The orchestrator moved to the synthesis phase, directing the critic to appraise risk of bias and produce a narrative synthesis focused on all-cause mortality, illness episodes (including Pneumocystis jiroveci pneumonia and serious bacterial infections), hospitalizations, and adverse events. It supplied the extracted evidence and review objective, requesting summaries of study characteristics, heterogeneity, precision/consistency, any antimicrobial resistance signals, and implications for low-resource settings and research gaps. The task reported completion without errors, but the synthesized narrative itself was not captured in this log.

> **Critic — Step 1 (result):** The critic aimed to appraise study quality and synthesize the extracted evidence for key outcomes. It evaluated the single included randomized, double-blind trial of cotrimoxazole in HIV-infected children, summarizing a clear reduction in all-cause mortality, limited and imprecisely reported safety/morbidity outcomes, and considerations of consistency and applicability; risk of bias was judged unclear due to early stopping and incomplete reporting, yielding an overall moderate quality rating. The agent produced a structured per‑study quality assessment and a concise narrative synthesis highlighting the mortality benefit, evidence gaps on morbidity/hospitalizations, and implications for practice and future research.

---

### 7. Final Output (Orchestrator)

*20:01:16 — 18s — 13,071 tokens*

The orchestrator assembled the final systematic review report on cotrimoxazole prophylaxis in children with HIV by combining outputs from screening, data extraction, and evidence synthesis. It summarized 10 candidate studies, with 1 randomized controlled trial included and 9 studies excluded, and recorded the screening decisions. The agent saved the structured evidence and search metadata, then returned the formatted report as the final deliverable.

---
